The aim of the in vitro study was a comparison of an allogenic (ABSM) and a xenogenic bone substitute material (XBSM) with and without injectable platelet-rich fibrin (ABSM-i-PRF & XBSM-i-PRF) on cell characteristics of human osteoblasts (HOB). Here, ABSM and XBSM (+ i-PRF = test; - i-PRF = control) were incubated with HOB for 3, 7 and 10 days. HOB viability, migration, proliferation and differentiation (RT-PCR on alkaline phosphatase (AP), bone morphogenetic protein 2 (BMP-2) and osteonectin (OCN)) were measured and compared between groups. At day 3, an increased viability, migration and proliferation was seen for ABSM-i-PRF. For viability and proliferation (days 7 and 10) and for migration (day 10), ABSM-i-PRF/XBSM-i-PRF showed higher values compared to ABSM/XBSM with maximum values for ABSM-i-PRF and minimum values for XBSM. At days 3 and 7, the highest expression of AP was detected in ABSM-i-PRF/XBSM-i-PRF when compared to ABSM/XBSM, whereas at day 10, AP expression levels were elevated in ABSM-i-PRF/ABSM. The highest BMP-2 expression was seen in ABSM-i-PRF whereas OCN expression showed higher levels in ABSM-i-PRF/XBSM-i-PRF at days 3 and 7 with lowest expression for ABSM. Later on, elevated OC levels were detected for ABSM-i-PRF only. In conclusion, i-PRF in combination with ABSM enhances HOB activity when compared to XBSM-i-PRF or untreated BSM in vitro. Therefore, addition of i-PRF to ABSM and – to a lower extent – to XBSM may influence osteoblast activity in vivo.
TilaveridisILazaridouMZouloumisL, et al.
The use of mineralized bone allograft as a single grafting material in maxillary sinus lifting with severely atrophied alveolar ridge (1–3 mm) and immediately inserted dental implants. A 3-up to 8-year retrospective study. Oral Maxillofac Surg2018;
22: 267–273.
2.
KlossFROffermannsV, Klosset al.Comparison of allogeneic and autogenous bone grafts for augmentation of alveolar ridge defects—a 12‐month retrospective radiographic evaluation. Clin Oral Impl Res2018;
29: 1163–1175.
3.
SchwartzZWeesnerTVan DijkS, et al.
Ability of deproteinized cancellous bovine bone to induce new bone formation. J Periodontol2000;
71: 1258–1269.
4.
KumarVVHellerMGötzH, et al.
Comparison of growth & function of endothelial progenitor cells cultured on deproteinized bovine bone modified with covalently bound fibronectin and bound vascular endothelial growth factor. Clin Oral Implants Res2017;
28: 543–550.
5.
MardingerOChaushuGSigalovS, et al.
Factors affecting changes in sinus graft height between and above the placed implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2011;
111: e6–e11.
6.
GapskiRNeivaROhT-J, et al.
Histologic analyses of human mineralized bone grafting material in sinus elevation procedures: a case series. Int J Periodontics Restorative Dent2006;
26: 59–69.
7.
MarxRECarlsonEREichstaedtRM, et al.
Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1998;
85: 638–646.
8.
WhitmanDHBerryRLGreenDM.Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg1997;
55: 1294–1299.
9.
Al -ZubeLBreitbartEAO’ConnorJP, et al.
Recombinant human platelet‐derived growth factor BB (rhPDGF‐BB) and beta‐tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res2009;
27: 1074–1081.
10.
MarianoRMessoraMde MoraisA, et al.
Bone healing in critical-size defects treated with platelet-rich plasma: a histologic and histometric study in the calvaria of diabetic rat. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2010;
109: 72–78.
11.
KleinMKämmererPWScholzT, et al.
Modulation of platelet activation and initial cytokine release by alloplastic bone substitute materials. Clin Oral Implants Res2010;
21: 336–345.
12.
KämmererPWSchiegnitzEAlshihriA, et al.
Modification of xenogenic bone substitute materials–effects on the early healing cascade in vitro. Clin Oral Implants Res2014;
25: 852–858.
13.
CenniECiapettiGPaganiS, et al.
Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol2005;
76: 323–328.
14.
GianniniSCieloABonanomeL, et al.
Comparison between PRP, PRGF and PRF: lights and shadows in three similar but different protocols. Eur Rev Med Pharmacol Sci2015;
19: 927–930.
15.
PaknejadMShayestehYSYaghobeeS, et al.
Evaluation of the effect of plasma rich in growth factors (PRGF) on bone regeneration. J Dentistry (Tehran, Iran)2012;
9: 59.
16.
WangXZhangYChoukrounJ, et al.
Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets2018;
29: 48–55.
17.
AnituaEPradoRTroyaM, et al.
Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: anticoagulant removal and reduction in activator concentration. Platelets2016;
27: 459–466.
18.
ChoukrounJAddaFSchoefflerC, et al.
Une opportunité en paro-implantologie: le PRF. Implantodontie2001;
42: e62.
19.
EhrenfestDMDDel CorsoMDissA, et al.
Three‐dimensional architecture and cell composition of a Choukroun’s platelet‐rich fibrin clot and membrane. J Periodontol2010;
81: 546–555.
20.
KangY-HJeonSHParkJ-Y, et al.
Platelet-rich fibrin is a Bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Eng Part A2010;
17: 349–359.
21.
SuCYKuoYPTsengYH, et al.
In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2009;
108: 56–61.
22.
Dohan EhrenfestDMde PeppoGMDoglioliP, et al.
Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors2009;
27: 63–69.
23.
HeLLinYHuX, et al.
A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2009;
108: 707–713.
24.
SinghAKohliMGuptaN.Platelet rich fibrin: a novel approach for osseous regeneration. J Maxillofac Oral Surg2012;
11: 430–434.
25.
ÖncüEErbeyoğluAA.Enhancement of immediate implant stability and recovery using platelet-rich fibrin. Int J Periodontics Restorative Dent2019;
39:
26.
EhrenfestDMDDissAOdinG, et al.
In vitro effects of Choukroun’s PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2009;
108: 341–352.
27.
Herrera-VizcaínoCDohleEAl-MaawiS, et al.
Platelet-rich fibrin secretome induces three dimensional angiogenic activation in vitro. Eur Cell Mater2019;
37: 250–264.
28.
TofflerMToscanoNHoltzclawD, et al.
Introducing Choukroun’s platelet rich fibrin (PRF) to the reconstructive surgery milieu. J Implant Adv Clin Dent2009;
1: 21–30.
29.
DohanDMChoukrounJDissA, et al.
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2006;
101: e37–e44.
30.
DohanDMChoukrounJDissA, et al.
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?Oral Surg Oral Med Oral Pathol Oral Radiol Endod2006;
101: e51–e55.
31.
DohanDMChoukrounJDissA, et al.
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features.Oral Surg Oral Med Oral Pathol Oral Radiol Endod2006;
101: e45–e50.
32.
GhanaatiSBoomsPOrlowskaA, et al.
Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol2014;
40: 679–689.
33.
ChoukrounJGhanaatiS.Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg2018;
44: 87–95.
34.
Abd El RaoufMWangXMiusiS, et al.
Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma. Platelets2019;
30: 213–221.
35.
MironRJZhangY.Autologous liquid platelet rich fibrin: a novel drug delivery system. Acta Biomater2018;
75: 35–51.
36.
KusumbeAPRamasamySKAdamsRH.Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature2014;
507: 323
FuchsSJiangXSchmidtH, et al.
Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials2009;
30: 1329–1338.
39.
LiangC-CParkAYGuanJ-L.In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc2007;
2: 329.
40.
OrthMShenarAKScheuerC, et al.
VEGF‐loaded mineral‐coated microparticles improve bone repair and are associated with increased expression of epo and RUNX‐2 in murine non‐unions. J Orthop Res2019;
37: 821–831.
41.
KrishnamurithyGMohanSYahyaNA, et al.
The physicochemical and biomechanical profile of forsterite and its osteogenic potential of mesenchymal stromal cells. PLoS One2019;
14: e0214212.
42.
DauMGanzCZaageF, et al.
In vivo comparison of a granular and putty form of a sintered and a non-sintered silica-enhanced hydroxyapatite bone substitute material. J Biomater Appl2019; 885328219877584-885328219872019. /09/24. DOI: 10.1177/0885328219877584.
43.
UristMR.Bone: formation by autoinduction. Science1965;
150: 893–899.
44.
BauerTWMuschlerGF.Bone graft materials: an overview of the basic science. Clinical Orthopaed Related Res2000;
371: 10–27.
45.
PiemonteseMAsprielloSDRubiniC, et al.
Treatment of periodontal intrabony defects with demineralized freeze‐dried bone allograft in combination with platelet‐rich plasma: a comparative clinical trial. J Periodontol2008;
79: 802–810.
46.
DelloyeCCornuODruezV, et al.
Bone allografts: what they can offer and what they cannot. J Bone Joint Surg Br2007;
89: 574–580.
47.
KatzJMNatarajCJawR, et al.
Demineralized bone matrix as an osteoinductive biomaterial and in vitro predictors of its biological potential. J Biomed Mater Res2009;
89: 127–134.
48.
KöndellPMattssonTÅstrandP.Immunological responses to maxillary on‐lay allogeneic bone grafts. Clin Oral Implants Res1996;
7: 373–377.
49.
UristM.Bone morphogenetic protein induced bone formation in experimental animals and patients with large bone defects. Cell and Molecular Biology of Vertebrate Hard Tissue London, CIBA Foundation1988: 231–239.
50.
Maria SoardiCSpinatoSZaffeD, et al.
Atrophic maxillary floor augmentation by mineralized human bone allograft in sinuses of different size: an histologic and histomorphometric analysis. Clin Oral Implants Res2011;
22: 560–566.
51.
TongDCRiouxKDrangsholtM, et al.
A review of survival rates for implants placed in grafted maxillary sinuses using meta-analysis. Int J Oral Maxillofac Implants1998;
13: 175–182.
52.
SolakogluÖSteinbachBGötzW, et al.
Characterization of circulating DNA in plasma of patients after allogeneic bone grafting. Clin Oral Invest2019; 23: 4243–4253.
53.
Fujioka -KobayashiMMironRJHernandezM, et al.
Optimized platelet‐rich fibrin with the low‐speed concept: growth factor release, biocompatibility, and cellular response. J Periodontol2017;
88: 112–121.
54.
KobayashiEFlückigerLFujioka-KobayashiM, et al.
Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig2016;
20: 2353–2360.
55.
WangXZhangYChoukrounJ, et al.
Behavior of gingival fibroblasts on titanium implant surfaces in combination with either injectable-PRF or PRP. Int J Mol Sci2017;
18: 331.
56.
LorenzJAl-MaawiSSaderR, et al.
Individualized titanium mesh combined with platelet-rich fibrin and deproteinized bovine bone: a new approach for challenging augmentation. J Oral Implantol2018;
44: 345–351.
57.
LeiLYuYKeT, et al.
The application of three-dimensional printing model and platelet-rich fibrin technology in guided tissue regeneration surgery for severe bone defects. J Oral Implantol2019;
45: 35–43.
58.
Mourão CFdAB ValienseHMeloER, et al.
Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft. Rev Col Bras Cir2015;
42: 421–423.
59.
KarayürekFKadirogluETNergizY, et al.
Combining platelet rich fibrin with different bone graft materials: An experimental study on the histopathological and immunohistochemical aspects of bone healing. J Craniomaxillofac Surg2019;
47: 815–825.
60.
TatulloMMarrelliMCassettaM, et al.
Platelet Rich Fibrin (PRF) in reconstructive surgery of atrophied maxillary bones: clinical and histological evaluations. Int J Med Sci2012;
9: 872.
61.
ZhangYTanglSHuberCD, et al.
Effects of Choukroun’s platelet-rich fibrin on bone regeneration in combination with deproteinized bovine bone mineral in maxillary sinus augmentation: a histological and histomorphometric study. J Craniomaxillofac Surg2012;
40: 321–328.
62.
BolukbasiNErsanlıSKeklikogluN, et al.
Sinus augmentation with platelet-rich fibrin in combination with bovine bone graft versus bovine bone graft in combination with collagen membrane. J Oral Implantol2015;
41: 586–595.
63.
AliSBakrySAAbd-ElhakamH.Platelet-rich fibrin in maxillary sinus augmentation: a systematic review. J Oral Implantol2015;
41: 746–753.
64.
YajamanyaSRChatterjeeABabuCN, et al.
Fibrin network pattern changes of platelet-rich fibrin in young versus old age group of individuals: a cell block cytology study. J Indian Soc Periodontol2016;
20: 151.
